Live Earnings Conference Call: Journey Medical will host a live Q2 2025 earnings call on August 12, 2025 at 4:30PM ET. Follow this link to get details and listen to Journey Medical's Q2 2025 earnings call when it goes live. Get details. Journey Medical (DERM) Institutional Ownership $8.67 +0.80 (+10.18%) As of 01:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Journey Medical (NASDAQ:DERM)CurrentInstitutional OwnershipPercentage7.25%Number ofInstitutional Buyers(last 12 months)16TotalInstitutional Inflows(last 12 months)$9.97MNumber ofInstitutional Sellers(last 12 months)12TotalInstitutional Outflows(last 12 months)$994.73K Get DERM Insider Trade Alerts Want to know when executives and insiders are buying or selling Journey Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DERM Institutional Buying and Selling by Quarter Journey Medical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2025 Cetera Investment Advisers10,731$77K0.0%-29.2%0.046% 8/8/2025 Creative Planning32,764$235K0.0%+178.5%0.141% 8/8/2025 Police & Firemen s Retirement System of New Jersey4,002$29K0.0%N/A0.017% 8/8/2025 Geode Capital Management LLC262,353$1.88M0.0%+130.7%1.126% 8/4/2025 Atria Investments Inc37,185$267K0.0%-16.7%0.160% 8/1/2025 Envestnet Asset Management Inc.69,991$503K0.0%-32.1%0.300% 7/31/2025 Brighton Jones LLC16,820$121K0.0%-26.9%0.072% 7/31/2025 Focus Partners Advisor Solutions LLC10,000$72K0.0%N/A0.043% 5/21/2025 Acadian Asset Management LLC4,772$28K0.0%-72.5%0.021% 5/19/2025Jane Street Group LLC18,599$110K0.0%N/A0.081% Get the Latest News and Ratings for DERM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025Integrated Wealth Concepts LLC56,850$335K0.0%-3.4%0.246% 5/15/2025Titleist Asset Management LLC12,900$76K0.0%+18.3%0.056% 5/14/2025Pale Fire Capital SE27,274$161K0.0%N/A0.118% 5/13/2025Kovitz Investment Group Partners LLC21,710$128K0.0%-12.1%0.094% 4/22/2025 Cambridge Investment Research Advisors Inc.338,050$1.99M0.0%+3.0%1.463% 2/17/2025Tang Capital Management LLC1,725,569$6.75M0.4%N/A8.260% 2/17/2025 Cetera Investment Advisers13,839$54K0.0%+21.8%0.066% 2/17/2025Citadel Advisors LLC44,568$174K0.0%N/A0.213% 2/14/2025Kovitz Investment Group Partners LLC24,710$97K0.0%+112.9%0.118% 2/14/2025Integrated Wealth Concepts LLC58,850$230K0.0%-4.1%0.282% 2/14/2025Dimensional Fund Advisors LP20,455$80K0.0%N/A0.098% 2/13/2025Renaissance Technologies LLC236,000$923K0.0%-12.0%1.130% 2/13/2025Titleist Asset Management LLC10,900$43K0.0%-23.5%0.052% 2/13/2025 Envestnet Asset Management Inc.103,557$405K0.0%-5.5%0.496% 1/29/2025Gladstone Institutional Advisory LLC29,981$117K0.0%-10.5%0.144% 11/25/2024PVG Asset Management Corp167,545$947K3.8%+5.7%0.802% 11/16/2024 Geode Capital Management LLC108,435$613K0.0%+13.5%0.523% 11/15/2024Kovitz Investment Group Partners LLC11,605$66K0.0%N/A0.056% 11/14/2024Walleye Capital LLC23,098$131K0.0%-63.7%0.111% 11/12/2024 Nwam LLC10,430$59K0.0%N/A0.050% 11/1/2024 Atria Investments Inc44,397$251K0.0%-19.8%0.214% 10/30/2024Rosalind Advisors Inc.105,917$598K0.4%-7.2%0.529% 10/11/2024 ORG Wealth Partners LLC19,519$110K0.0%N/A0.094% 8/22/2024PVG Asset Management Corp158,540$894K3.5%N/A0.792% 8/9/2024Renaissance Technologies LLC264,025$1.49M0.0%-2.4%1.319% 8/8/2024TMD Wealth Management LLC11,605$65K0.0%N/A0.058% 8/6/2024 Acadian Asset Management LLC94,404$531K0.0%-57.6%0.472% 7/26/2024 Cambridge Investment Research Advisors Inc.294,950$1.66M0.0%N/A1.474% 7/12/2024Rosalind Advisors Inc.114,132$644K0.5%N/A0.570% 5/14/2024Heron Bay Capital Management33,669$124K0.0%N/A0.169% China Just Declared War on the Dollar (Ad)While headlines focus on tariffs, the real story is playing out in global currency markets. China has been quietly shedding U.S. debt—and this week, they accelerated their dump. Major financial outlets are calling it “currency warfare.” If your retirement is dollar-based, the risk is real.Learn how to protect what’s yours with one move.5/10/2024 Acadian Asset Management LLC222,663$817K0.0%+687.5%1.117% 5/10/2024 Perkins Capital Management Inc.22,000$81K0.1%-31.3%0.110% 5/10/2024 Nwam LLC11,820$41K0.0%N/A0.059% (Data available from 1/1/2016 forward) DERM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DERM shares? During the previous two years, 28 institutional investors and hedge funds held shares of Journey Medical. The most heavily invested institutionals were Tang Capital Management LLC ($6.75M), Cambridge Investment Research Advisors Inc. ($1.99M), Geode Capital Management LLC ($1.88M), PVG Asset Management Corp ($947K), Renaissance Technologies LLC ($923K), Rosalind Advisors Inc. ($598K), and Envestnet Asset Management Inc. ($503K).Learn more on Journey Medical's institutional investors. What percentage of Journey Medical's stock is owned by institutional investors? 7.25% of Journey Medical's stock is owned by institutional investors. Learn more on DERM's institutional investor holdings. Which institutional investors have been buying Journey Medical's stock? Of the 20 institutional investors that purchased Journey Medical's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Tang Capital Management LLC ($1.73M), Cambridge Investment Research Advisors Inc. ($304.89K), Acadian Asset Management LLC ($194.39K), PVG Asset Management Corp ($167.55K), Geode Capital Management LLC ($161.49K), Rosalind Advisors Inc. ($114.13K), and Citadel Advisors LLC ($44.57K). How much institutional buying is happening at Journey Medical? Institutional investors have bought a total of 2,269,581 shares in the last 24 months. This purchase volume represents approximately $9.97M in transactions. Which of Journey Medical's major shareholders have been selling company stock? Of the 12 institutional investors that sold Journey Medical's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Walleye Capital LLC ($40.48K), Envestnet Asset Management Inc. ($39.19K), Renaissance Technologies LLC ($32.20K), Atria Investments Inc ($18.41K), Acadian Asset Management LLC ($12.59K), Rosalind Advisors Inc. ($8.22K), and Brighton Jones LLC ($6.20K). How much institutional selling is happening at Journey Medical? Institutional investors have sold a total of 176,054 shares in the last 24 months. This volume of shares sold represents approximately $994.73K in transactions. Related Companies Fortress Biotech Institutional Ownership ArriVent BioPharma Institutional Ownership Mind Medicine (MindMed) Institutional Ownership Arbutus Biopharma Institutional Ownership Autolus Therapeutics Institutional Ownership Gyre Therapeutics Institutional Ownership MeiraGTx Institutional Ownership Valneva Institutional Ownership Zevra Therapeutics Institutional Ownership Prime Medicine Institutional Ownership This page (NASDAQ:DERM) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisChris Rowe has made legendary calls—Tesla at $13, Nvidia at $40, Bitcoin under $1,000, Amazon at 12 cents. Now...True Market Insiders | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.